chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Magnetic resonance imaging head abnormal
Clinical narrative: Reported Symptoms: 10013573:DIZZINESS;  10019211:HEADACHE; 10020772:HYPERTENSION;   Narrative: 10/26/22:  This is a 43-year-old male who presents the emergency department via private vehicle ambulatory.  Patient reports that he was at this facility as he is an employee here and began to have some dizziness.  He describes the dizziness as lightheadedness.  States he checked his blood pressure and it was high.  States the patient continued to have symptoms and so came to the emergency department for further evaluation.  Also complains of a headache associated  with this. States the headache is left-sided and frontal.  Patient admitted.  Chest x-ray and CT head  were unremarkable.  Discharged 10/27:discharge diagnosis: headache and abnormal gait  12/20/22: primary care walk-in visit: Patient presents to clinic today for unscheduled visit to discuss his current health status.  Patient is employee here. On 26 Oct 22 while on his shift he began feeling dizzy and co HA. He was seen in ER and had head CT to  rule out CVA. Was scheduled next day for MRI.  The MRI did show some abnormality  of pituitary and fu MRI w/contrast recommended in 4 mths.  However, patient  scheduled MRA on 10 Nov which was noncontributory and brain MRI w/wo on 15 Nov.  Study did show a possible 2-3mm pituitary microadenoma.  As noted patient has aldo seen a neurologist, endocrinologist, and ENT.  Also Internal Med.  Today patient is accompanied by spouse who is also employee here. They are requesting information on the status of a neruorlogy consult here which was  apparently
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Respiratory depression, Sepsis
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10035755:PNEUMONITIS NOS: 10038678:RESPIRATORY DEPRESSION; 10040047:SEPSIS; Narrative: Patient received five doses of Pfizer COVID 19 Vaccine Jan/Feb. The patient presented to the ED on 14 Dec 2022 with cough, shortness of breath, and sepsis. The patient tested positive for COVID 19 and was admitted with COVID pneumonitis and sepsis. The patient was treated with antibiotics, dexamethasone, and nebulizers. The patient was discharged on 15 Dec 22 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19 sepsis and pneumonitis
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Abdominal pain, Acute kidney injury, Angina pectoris, Asthenia, COVID-19
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10012727:DIARRHEA; 10028411:MYALGIA, 10038436:RENAL FAILURE ACUTE; 10047700:VOMITING; 10084268:COVID-19; Narrative: Patient received four doses of Pfizer COVID 19 Vaccine (Feb/Mar/Sep 2021 and May 22) and one dose Moderna Booster COVID 19 Vaccine on 8 Dec 2022. The patient recalls having symptoms of cough and chest pain soon after receiving the Booster vaccine. The patient presented to the ED on 10 Dec 2022 with cough, chest pain, weakness, and diarrhea. The patient tested positive for COVID 19 on 10 Dec 22, but she was sent home. The patient returned to the ED on 17 Dec 22 with continuation of abdominal pain, diarrhea, mucus and cough. The patient was admitted to the hospital with acute kidney injury, COVID 19, and gastroenteritis. The patient left AMA on 18 December. No other communication was noted. Reported per EUA. Other Relevant HX: Other: covid 19
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Chest pain, Cough, Diarrhoea, Gastroenteritis, Myalgia
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10012727:DIARRHEA; 10028411:MYALGIA, 10038436:RENAL FAILURE ACUTE; 10047700:VOMITING; 10084268:COVID-19; Narrative: Patient received four doses of Pfizer COVID 19 Vaccine (Feb/Mar/Sep 2021 and May 22) and one dose Moderna Booster COVID 19 Vaccine on 8 Dec 2022. The patient recalls having symptoms of cough and chest pain soon after receiving the Booster vaccine. The patient presented to the ED on 10 Dec 2022 with cough, chest pain, weakness, and diarrhea. The patient tested positive for COVID 19 on 10 Dec 22, but she was sent home. The patient returned to the ED on 17 Dec 22 with continuation of abdominal pain, diarrhea, mucus and cough. The patient was admitted to the hospital with acute kidney injury, COVID 19, and gastroenteritis. The patient left AMA on 18 December. No other communication was noted. Reported per EUA. Other Relevant HX: Other: covid 19
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: SARS-CoV-2 test positive, Secretion discharge, Vomiting
Clinical narrative: Reported Symptoms: 10002391:ANGINAL PAIN; 10012727:DIARRHEA; 10028411:MYALGIA, 10038436:RENAL FAILURE ACUTE; 10047700:VOMITING; 10084268:COVID-19; Narrative: Patient received four doses of Pfizer COVID 19 Vaccine (Feb/Mar/Sep 2021 and May 22) and one dose Moderna Booster COVID 19 Vaccine on 8 Dec 2022. The patient recalls having symptoms of cough and chest pain soon after receiving the Booster vaccine. The patient presented to the ED on 10 Dec 2022 with cough, chest pain, weakness, and diarrhea. The patient tested positive for COVID 19 on 10 Dec 22, but she was sent home. The patient returned to the ED on 17 Dec 22 with continuation of abdominal pain, diarrhea, mucus and cough. The patient was admitted to the hospital with acute kidney injury, COVID 19, and gastroenteritis. The patient left AMA on 18 December. No other communication was noted. Reported per EUA. Other Relevant HX: Other: covid 19
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Confusional state, Cough, Encephalopathy
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10014625:ENCEPHALOPATHY; 10033556:PALPITATION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: Patient has received four doses of Pfizer COVID 19 Vaccine in Feb/Oct 2021 and Nov 2022. The patient presented to the ED on 5 Dec 2022 with cough, confusion, and new onset a fib. The patient was diagnosed with COVID 19 and admitted to the hospital with afib, encephalopathy, and COVID 19. The patient was treated with diltiazem, cough medicine, and oxygen. The patient was discharged in stable condition on 15 Dec 2022. Reported per EUA. Other Relevant HX: Other: COVID 19 Encephalopathy
Age: 86.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Reported Symptoms: 10010300:CONFUSION; 10014625:ENCEPHALOPATHY; 10033556:PALPITATION; 10084401:COVID-19 RESPIRATORY INFECTION; Narrative: Patient has received four doses of Pfizer COVID 19 Vaccine in Feb/Oct 2021 and Nov 2022. The patient presented to the ED on 5 Dec 2022 with cough, confusion, and new onset a fib. The patient was diagnosed with COVID 19 and admitted to the hospital with afib, encephalopathy, and COVID 19. The patient was treated with diltiazem, cough medicine, and oxygen. The patient was discharged in stable condition on 15 Dec 2022. Reported per EUA. Other Relevant HX: Other: COVID 19 Encephalopathy
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Condition aggravated, Deep vein thrombosis, Hypertensive urgency
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 67 yo male patient w/ PMH for HTN, HLD, OSA, OA, alcohol dependence, chronic smoker and PTSD presented to ED on 09/23/22 with 2 weeks of left leg pain and swelling. Pt dx w/ bilateral PE, left leg DVT and COVID 19 positive. Pt admitted to hospital for further evaluation and treatment. On 9/24 pt w/ acute hypoxic respiratory failure and was most likely secondary to bilateral pulmonary embolism and possible COVID-19 infection. Pt treated with dexamethasone (9/25-9/29). Pt oxygen sat improved to 100% on room air. Pt treated for PE, DVT and hypertensive urgency during hospitalization. Pt improved and discharged to home on 9/29/22. Other Relevant HX: 67 yo male patient w/ PMH for HTN, HLD, OSA, OA, alcohol dependence and PTSD. Other: COVID Infection w/ hospitalization
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pulmonary embolism, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 67 yo male patient w/ PMH for HTN, HLD, OSA, OA, alcohol dependence, chronic smoker and PTSD presented to ED on 09/23/22 with 2 weeks of left leg pain and swelling. Pt dx w/ bilateral PE, left leg DVT and COVID 19 positive. Pt admitted to hospital for further evaluation and treatment. On 9/24 pt w/ acute hypoxic respiratory failure and was most likely secondary to bilateral pulmonary embolism and possible COVID-19 infection. Pt treated with dexamethasone (9/25-9/29). Pt oxygen sat improved to 100% on room air. Pt treated for PE, DVT and hypertensive urgency during hospitalization. Pt improved and discharged to home on 9/29/22. Other Relevant HX: 67 yo male patient w/ PMH for HTN, HLD, OSA, OA, alcohol dependence and PTSD. Other: COVID Infection w/ hospitalization
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, COVID-19, Dysphagia, Dyspnoea, Hypoxia
Clinical narrative: Reported Symptoms: 10038436:RENAL FAILURE ACUTE; 10038678:RESPIRATORY DEPRESSION; 10043088:TACHYPNEA; 10084268:COVID-19; Narrative: The patient received four doses of Pfizer COVID 19 vaccine (Feb/Mar/Sep 2021, and Apr 2022). The patient presented to the ED with dysphagia and shortness of breath on 13 Dec 2022. The patient was diagnosed with covid 19 and was admitted with COVID 19 hypoxia, and acute renal failure. The patient was treated with oxygen, dexamethasone, and IV fluids. The patient was discharged on 23 Dec 22 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Respiratory depression, Tachypnoea
Clinical narrative: Reported Symptoms: 10038436:RENAL FAILURE ACUTE; 10038678:RESPIRATORY DEPRESSION; 10043088:TACHYPNEA; 10084268:COVID-19; Narrative: The patient received four doses of Pfizer COVID 19 vaccine (Feb/Mar/Sep 2021, and Apr 2022). The patient presented to the ED with dysphagia and shortness of breath on 13 Dec 2022. The patient was diagnosed with covid 19 and was admitted with COVID 19 hypoxia, and acute renal failure. The patient was treated with oxygen, dexamethasone, and IV fluids. The patient was discharged on 23 Dec 22 in stable condition. Reported per EUA. Other Relevant HX: Other: covid 19
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chest X-ray normal, Nausea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male patient with PMH for metastatic urothelial cancer on palliative chemo presented to ED on 10/17/22 with 4 to 5 days of nausea/vomiting and fevers. COVID Positive. CXR negative. Admitted to hospital due to immunocompromised state and concern for progressive disease. Patient treated with dexamethasone on 10/18 @ 0030 and 1319. Treated with remdesivir on 10/18 @ 0041 and 1321. Patient was never hypoxic or in respiratory failure. Patient requested to be discharged on 10/18/22 stating he had no medical complaints and felt his usual state of health. Patient agreed to return if fever returned or had any additional medical symptoms. Patient discharged to home on 10/18/22. Other Relevant HX: 72 yo male patient with PMH for metastatic urothelial cancer on palliative chemo. Other: Covid Infection w/ hospitalization
Age: 71.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 72 yo male patient with PMH for metastatic urothelial cancer on palliative chemo presented to ED on 10/17/22 with 4 to 5 days of nausea/vomiting and fevers. COVID Positive. CXR negative. Admitted to hospital due to immunocompromised state and concern for progressive disease. Patient treated with dexamethasone on 10/18 @ 0030 and 1319. Treated with remdesivir on 10/18 @ 0041 and 1321. Patient was never hypoxic or in respiratory failure. Patient requested to be discharged on 10/18/22 stating he had no medical complaints and felt his usual state of health. Patient agreed to return if fever returned or had any additional medical symptoms. Patient discharged to home on 10/18/22. Other Relevant HX: 72 yo male patient with PMH for metastatic urothelial cancer on palliative chemo. Other: Covid Infection w/ hospitalization
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Asthenia, COVID-19, Confusional state, Decreased appetite, Fatigue
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient with PMH for HTN, HLD, PVD, CAD, GERD, DM, and COPD presented to ED on 10/27/22 with diminished appetite, fatigue, weakness, and intermittent confusion for 2 days. Pt found to be COVID positive and admited to hospital for further evaluation and treatment. Pt received dexamethasone (10/27-10/28). Pt with mild symptoms throughout hospital stay. Pt improved and discharged back to group home on 11/2/22. Other Relevant X; 77 yo male patient with PMH for HTN, HLD, PVD, CAD, GERD, DM, and COPD. Other: Covid Infection w/ hospitalization
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms:  10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient with PMH for HTN, HLD, PVD, CAD, GERD, DM, and COPD presented to ED on 10/27/22 with diminished appetite, fatigue, weakness, and intermittent confusion for 2 days. Pt found to be COVID positive and admited to hospital for further evaluation and treatment. Pt received dexamethasone (10/27-10/28). Pt with mild symptoms throughout hospital stay. Pt improved and discharged back to group home on 11/2/22. Other Relevant X; 77 yo male patient with PMH for HTN, HLD, PVD, CAD, GERD, DM, and COPD. Other: Covid Infection w/ hospitalization
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Dehydration, Diabetic ketoacidosis
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for T2DM, HTN, HLD, GERD, CAD, CKD 3, and previous C. difficile infection presented to ED on 10/21/22 w/ complaint of feeling dehydrated, N/V and diarrhea. Patient dx w/ DKA, COVID 19, and acute on chronic renal insufficiency. Patient started on insulin drip and admitted to MICU 10/21/22. Pt downgraded to medical telemetry/Covid Unit 10/22/2022. Pt with acute hypoxic respiratory failure due to COVID PNA and MSSA PNA. Pt received IV Vancomycin (10/21-10/23) and Cefazolin (10/23-11/3). Pt received remdesivir (10/21-10/25) and dexamethasone (10/21-10/22). Dexamethasone d/c'd due to improvement of hypoxia and to avoid losing control of blood sugar. Pt condition improved and discharged to home on 11/3/22. Other Relevant HX: 70 yo male patient with PMH of T2DM, HTN, HLD, GERD, CKD 3, CAD and previous C. difficile infection. Other: Covid Infection w/ hospitalization
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Intensive care, Nausea, Pneumonia staphylococcal, Renal failure
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for T2DM, HTN, HLD, GERD, CAD, CKD 3, and previous C. difficile infection presented to ED on 10/21/22 w/ complaint of feeling dehydrated, N/V and diarrhea. Patient dx w/ DKA, COVID 19, and acute on chronic renal insufficiency. Patient started on insulin drip and admitted to MICU 10/21/22. Pt downgraded to medical telemetry/Covid Unit 10/22/2022. Pt with acute hypoxic respiratory failure due to COVID PNA and MSSA PNA. Pt received IV Vancomycin (10/21-10/23) and Cefazolin (10/23-11/3). Pt received remdesivir (10/21-10/25) and dexamethasone (10/21-10/22). Dexamethasone d/c'd due to improvement of hypoxia and to avoid losing control of blood sugar. Pt condition improved and discharged to home on 11/3/22. Other Relevant HX: 70 yo male patient with PMH of T2DM, HTN, HLD, GERD, CKD 3, CAD and previous C. difficile infection. Other: Covid Infection w/ hospitalization
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vomiting
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 70 yo male patient with PMH for T2DM, HTN, HLD, GERD, CAD, CKD 3, and previous C. difficile infection presented to ED on 10/21/22 w/ complaint of feeling dehydrated, N/V and diarrhea. Patient dx w/ DKA, COVID 19, and acute on chronic renal insufficiency. Patient started on insulin drip and admitted to MICU 10/21/22. Pt downgraded to medical telemetry/Covid Unit 10/22/2022. Pt with acute hypoxic respiratory failure due to COVID PNA and MSSA PNA. Pt received IV Vancomycin (10/21-10/23) and Cefazolin (10/23-11/3). Pt received remdesivir (10/21-10/25) and dexamethasone (10/21-10/22). Dexamethasone d/c'd due to improvement of hypoxia and to avoid losing control of blood sugar. Pt condition improved and discharged to home on 11/3/22. Other Relevant HX: 70 yo male patient with PMH of T2DM, HTN, HLD, GERD, CKD 3, CAD and previous C. difficile infection. Other: Covid Infection w/ hospitalization
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, CHA2DS2-VASc-score, COVID-19, Cough, Fatigue
Clinical narrative: Reported Symptoms: 10000424:ACHE; 10011232:COUGHING; 10016256:FATIGUE; 10016558:FEVER; 10028735:NASAL CONGESTION; Narrative: 1/31/23 - Pt presented to ED with 2 days of cough, nasal congestion, and fatigue. Pt went to office (earlier on 1/31) where he tested COVID positive. MD at office heard heart irregularity and ordered an EKG. Pt was instructed to present to facility for follow-up of Irregular heart rate. Pt did deny chest pain. Provider also noted Pt with body aches and fever. Pt noted to have atrial fibrillation with rapid ventricular response that is new diagnosis for him. MEDICAL DECISION MAKING (MDM): New onset atrial fibrillation. Will need anticoagulation and cardiac work-up and rate control with IV medications to slow rate. ED Course: Patient was given acetaminophen for his fever and oral metoprolol IV and repeated doses for his heart rate. ***patient admitted 1/31 - 2/1/23*** Principal Diagnosis (reason for admission after study): Persistent atrial fibrillation new onset with rapid ventricular response ADDITIONAL DIAGNOSES: COVID viral syndrome Major depressive disorder HOSPITAL COURSE: Patient admitted to SDU due to rapid HR, which mostly improved with initial interventions, and ranged from 85-120 at rest after that without ongoign rate control. I believe that he contracted COVID from family members which caused increased atrial irritability and fib in this otherwise healthy patient with no cardiac history. Await echo, will have ambulatory tele monitoring ordered for discharge to assess when/if he returns to sinus. His Chads-vasc is 0,
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate increased, Heart rate irregular, Major depression, Nasal congestion, Pain
Clinical narrative: Reported Symptoms: 10000424:ACHE; 10011232:COUGHING; 10016256:FATIGUE; 10016558:FEVER; 10028735:NASAL CONGESTION; Narrative: 1/31/23 - Pt presented to ED with 2 days of cough, nasal congestion, and fatigue. Pt went to office (earlier on 1/31) where he tested COVID positive. MD at office heard heart irregularity and ordered an EKG. Pt was instructed to present to facility for follow-up of Irregular heart rate. Pt did deny chest pain. Provider also noted Pt with body aches and fever. Pt noted to have atrial fibrillation with rapid ventricular response that is new diagnosis for him. MEDICAL DECISION MAKING (MDM): New onset atrial fibrillation. Will need anticoagulation and cardiac work-up and rate control with IV medications to slow rate. ED Course: Patient was given acetaminophen for his fever and oral metoprolol IV and repeated doses for his heart rate. ***patient admitted 1/31 - 2/1/23*** Principal Diagnosis (reason for admission after study): Persistent atrial fibrillation new onset with rapid ventricular response ADDITIONAL DIAGNOSES: COVID viral syndrome Major depressive disorder HOSPITAL COURSE: Patient admitted to SDU due to rapid HR, which mostly improved with initial interventions, and ranged from 85-120 at rest after that without ongoign rate control. I believe that he contracted COVID from family members which caused increased atrial irritability and fib in this otherwise healthy patient with no cardiac history. Await echo, will have ambulatory tele monitoring ordered for discharge to assess when/if he returns to sinus. His Chads-vasc is 0,
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Tachycardia, Viral infection
Clinical narrative: Reported Symptoms: 10000424:ACHE; 10011232:COUGHING; 10016256:FATIGUE; 10016558:FEVER; 10028735:NASAL CONGESTION; Narrative: 1/31/23 - Pt presented to ED with 2 days of cough, nasal congestion, and fatigue. Pt went to office (earlier on 1/31) where he tested COVID positive. MD at office heard heart irregularity and ordered an EKG. Pt was instructed to present to facility for follow-up of Irregular heart rate. Pt did deny chest pain. Provider also noted Pt with body aches and fever. Pt noted to have atrial fibrillation with rapid ventricular response that is new diagnosis for him. MEDICAL DECISION MAKING (MDM): New onset atrial fibrillation. Will need anticoagulation and cardiac work-up and rate control with IV medications to slow rate. ED Course: Patient was given acetaminophen for his fever and oral metoprolol IV and repeated doses for his heart rate. ***patient admitted 1/31 - 2/1/23*** Principal Diagnosis (reason for admission after study): Persistent atrial fibrillation new onset with rapid ventricular response ADDITIONAL DIAGNOSES: COVID viral syndrome Major depressive disorder HOSPITAL COURSE: Patient admitted to SDU due to rapid HR, which mostly improved with initial interventions, and ranged from 85-120 at rest after that without ongoign rate control. I believe that he contracted COVID from family members which caused increased atrial irritability and fib in this otherwise healthy patient with no cardiac history. Await echo, will have ambulatory tele monitoring ordered for discharge to assess when/if he returns to sinus. His Chads-vasc is 0,
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Acute kidney injury, Chills, Dehydration, Diarrhoea, Headache
Clinical narrative: Reported Symptoms: 10008531:CHILLS; 10012174:DEHYDRATION; 10819211:HEADACHE; 10042661:SWEATING; 10047700:VOMITING; 10063889:ORAL INTAKE REDUCED; Narrative: patient with 1st shingles vaccine 2/1/23. Reported vomiting and chills after vaccine was given. 2 days after vaccine, patient complained of nausea, vomiting, chills, sweats, diarrhea, runny nose and headache. On 2/6/23, continued s/sx despite ondansetron use. Recommended ED evaluation. ED evaluation 2/7/23-dx dehydration, acute kidney injury and hyponatremia. Admitted then transferred to MC due to obstructing renal stone with moderate hydro nephrosis. Other Relevant HX: Other: chills, sweats, limited oral intake, dehydration
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Hydronephrosis, Hyperhidrosis, Hyponatraemia, Hypophagia, Nausea
Clinical narrative: Reported Symptoms: 10008531:CHILLS; 10012174:DEHYDRATION; 10819211:HEADACHE; 10042661:SWEATING; 10047700:VOMITING; 10063889:ORAL INTAKE REDUCED; Narrative: patient with 1st shingles vaccine 2/1/23. Reported vomiting and chills after vaccine was given. 2 days after vaccine, patient complained of nausea, vomiting, chills, sweats, diarrhea, runny nose and headache. On 2/6/23, continued s/sx despite ondansetron use. Recommended ED evaluation. ED evaluation 2/7/23-dx dehydration, acute kidney injury and hyponatremia. Admitted then transferred to MC due to obstructing renal stone with moderate hydro nephrosis. Other Relevant HX: Other: chills, sweats, limited oral intake, dehydration
Age: 75.0
Sex: M
Vaccine: VARZOS
Symptoms: Nephrolithiasis, Rhinorrhoea, Vomiting
Clinical narrative: Reported Symptoms: 10008531:CHILLS; 10012174:DEHYDRATION; 10819211:HEADACHE; 10042661:SWEATING; 10047700:VOMITING; 10063889:ORAL INTAKE REDUCED; Narrative: patient with 1st shingles vaccine 2/1/23. Reported vomiting and chills after vaccine was given. 2 days after vaccine, patient complained of nausea, vomiting, chills, sweats, diarrhea, runny nose and headache. On 2/6/23, continued s/sx despite ondansetron use. Recommended ED evaluation. ED evaluation 2/7/23-dx dehydration, acute kidney injury and hyponatremia. Admitted then transferred to MC due to obstructing renal stone with moderate hydro nephrosis. Other Relevant HX: Other: chills, sweats, limited oral intake, dehydration
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Acute respiratory failure, Brain natriuretic peptide increased, COVID-19, Cough, Dyspnoea
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 80 yo male patient with PMH for, HTN, CAD, GERD, HLD, COPD, DM, T1b lung cancer with metastatic adenocarcinoma in the liver and with lung metastasis and bone mets presented to ED with SOB for 2 weeks, lower extremity edema and dry cough. Pt admitted and given supplemental oxygen to keep SPO2 > 98%. Dexamethasone (11/9-11/11) and remdesivir (11/8-11/11) given in the setting of acute hypoxic respiratory failure due to COVID-19. Pt w/ heart failure with preserved ejection fraction exacerbation with BNP elevated at 631. Pt given IV furosemide for diuresis. Patient weaned off supplemental oxygen and requested discharged to home. Pt to complete remainder of 10 day course of dexamethasone at home. Discharged 11/11/22. Other Relevant HX: 80 yo male patient with PMH for T1b lung cancer with metastatic adenocarcinoma in the liver and with lung metastasis and bone mets. Other: COVID Infection w/ hospitalization
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: Heart failure with preserved ejection fraction, Oedema peripheral, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 80 yo male patient with PMH for, HTN, CAD, GERD, HLD, COPD, DM, T1b lung cancer with metastatic adenocarcinoma in the liver and with lung metastasis and bone mets presented to ED with SOB for 2 weeks, lower extremity edema and dry cough. Pt admitted and given supplemental oxygen to keep SPO2 > 98%. Dexamethasone (11/9-11/11) and remdesivir (11/8-11/11) given in the setting of acute hypoxic respiratory failure due to COVID-19. Pt w/ heart failure with preserved ejection fraction exacerbation with BNP elevated at 631. Pt given IV furosemide for diuresis. Patient weaned off supplemental oxygen and requested discharged to home. Pt to complete remainder of 10 day course of dexamethasone at home. Discharged 11/11/22. Other Relevant HX: 80 yo male patient with PMH for T1b lung cancer with metastatic adenocarcinoma in the liver and with lung metastasis and bone mets. Other: COVID Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient with PMH for ESRD on HD MWF, Obesity, CAD, HTN, HLD, Amyloidosis, and OSA presented to ED on 09/14/22 with cough, SOB, diarrhea and body aches. Patient tested positive for COVID at home 5 days prior and symptoms progressed. CXR showed possible edema/volume overload. Initially sats were in the 70s in triage, but stabilized on 3L nasal cannula in the ED. Patient admitted for COVID-19 and acute hypoxic respiratory failure. Patient given dexamethasone (09/14/22 for 10 days) for COVID pneumonia. Unable to receive remdesivir d/t kidney disease. Patient continued to undergo routine dialysis. Oxygenation continued to improve and patient was eventually able to wean off oxygen. Pt discharged to home on 09/20/22 with remaining four day supply of dexamethasone. Other Relevant HX: 77 yo male patient with PMH for ESRD on HD MWF, Obesity, HTN, HLD, Amyloidosis, and OSA. Other: COVID Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Dyspnoea, Pain, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient with PMH for ESRD on HD MWF, Obesity, CAD, HTN, HLD, Amyloidosis, and OSA presented to ED on 09/14/22 with cough, SOB, diarrhea and body aches. Patient tested positive for COVID at home 5 days prior and symptoms progressed. CXR showed possible edema/volume overload. Initially sats were in the 70s in triage, but stabilized on 3L nasal cannula in the ED. Patient admitted for COVID-19 and acute hypoxic respiratory failure. Patient given dexamethasone (09/14/22 for 10 days) for COVID pneumonia. Unable to receive remdesivir d/t kidney disease. Patient continued to undergo routine dialysis. Oxygenation continued to improve and patient was eventually able to wean off oxygen. Pt discharged to home on 09/20/22 with remaining four day supply of dexamethasone. Other Relevant HX: 77 yo male patient with PMH for ESRD on HD MWF, Obesity, HTN, HLD, Amyloidosis, and OSA. Other: COVID Infection w/ hospitalization
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Ageusia, Antiplatelet therapy, Atrial fibrillation
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignancy presentd to ED on 11/27/22 with cough, clear sputum and loss of taste. Pt w/ recent admission on 11/16-11/25 for NSTEMI, AFib, and AKI. Pt tested positive for COVID on 11/22 prior to discharge. He did not receive tx for COVID on prior admission. Pt tested positive for COVID on 11/27 and was admitted to hospital for same, episode of melena/bright red blood per rectum in the setting of DAPT, Afib with episode of RVR, and chronic iron deficiency. Pt received remdesivir (11/28 @ 0022 & 1643, 11/29) for COVID-19. Patient remained stable with no hypoxia. Pt improved, medically stable and discharged to CNH on 12/07/22. Other Relevant HX: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignacy. Other: Covid Infection w/ hospitalization
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Iron deficiency, Melaena, Productive cough
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignancy presentd to ED on 11/27/22 with cough, clear sputum and loss of taste. Pt w/ recent admission on 11/16-11/25 for NSTEMI, AFib, and AKI. Pt tested positive for COVID on 11/22 prior to discharge. He did not receive tx for COVID on prior admission. Pt tested positive for COVID on 11/27 and was admitted to hospital for same, episode of melena/bright red blood per rectum in the setting of DAPT, Afib with episode of RVR, and chronic iron deficiency. Pt received remdesivir (11/28 @ 0022 & 1643, 11/29) for COVID-19. Patient remained stable with no hypoxia. Pt improved, medically stable and discharged to CNH on 12/07/22. Other Relevant HX: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignacy. Other: Covid Infection w/ hospitalization
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Prostate cancer, Rectal haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignancy presentd to ED on 11/27/22 with cough, clear sputum and loss of taste. Pt w/ recent admission on 11/16-11/25 for NSTEMI, AFib, and AKI. Pt tested positive for COVID on 11/22 prior to discharge. He did not receive tx for COVID on prior admission. Pt tested positive for COVID on 11/27 and was admitted to hospital for same, episode of melena/bright red blood per rectum in the setting of DAPT, Afib with episode of RVR, and chronic iron deficiency. Pt received remdesivir (11/28 @ 0022 & 1643, 11/29) for COVID-19. Patient remained stable with no hypoxia. Pt improved, medically stable and discharged to CNH on 12/07/22. Other Relevant HX: 91 male patient w/ PMH for CAD with recent admission for NSTEMI, paroxysmal Atrial Fibrillation, and prostate malignacy. Other: Covid Infection w/ hospitalization
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, COVID-19, Chest X-ray abnormal, Chills, Condition aggravated
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P stats post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety presented to ED on 11/19/22 with 5 days of body aches, productive cough, brown sputum, diarrhea, fever and chills. Pt was recently inpatient for opiate detox until 4 days prior. Pt tested positive for COVID-19 and admitted to hospital. Pt received remdesivir (11/20-11/24), prednisone (11/20-11/26), ceftriaxone (11/20-11/24) and azithromycin (11/20-11/23). Pt treated for COVID and CAP. Pt positive for strep pna on 11/22. Pt continued to improve. Pt stable on 11/26 and discharged to home. Pt was to follow up with Pulmonology for repeat CT chest in 6 weeks regarding CTA findings. Other Relevant HX: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P status post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety. Other: COVID infection w/ hospitalization
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Coronary artery disease, Diarrhoea, Drug detoxification, Lung infiltration, Lung opacity
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P stats post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety presented to ED on 11/19/22 with 5 days of body aches, productive cough, brown sputum, diarrhea, fever and chills. Pt was recently inpatient for opiate detox until 4 days prior. Pt tested positive for COVID-19 and admitted to hospital. Pt received remdesivir (11/20-11/24), prednisone (11/20-11/26), ceftriaxone (11/20-11/24) and azithromycin (11/20-11/23). Pt treated for COVID and CAP. Pt positive for strep pna on 11/22. Pt continued to improve. Pt stable on 11/26 and discharged to home. Pt was to follow up with Pulmonology for repeat CT chest in 6 weeks regarding CTA findings. Other Relevant HX: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P status post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety. Other: COVID infection w/ hospitalization
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy mediastinal, Pain, Productive cough, Pulmonary mass, Pyrexia
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P stats post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety presented to ED on 11/19/22 with 5 days of body aches, productive cough, brown sputum, diarrhea, fever and chills. Pt was recently inpatient for opiate detox until 4 days prior. Pt tested positive for COVID-19 and admitted to hospital. Pt received remdesivir (11/20-11/24), prednisone (11/20-11/26), ceftriaxone (11/20-11/24) and azithromycin (11/20-11/23). Pt treated for COVID and CAP. Pt positive for strep pna on 11/22. Pt continued to improve. Pt stable on 11/26 and discharged to home. Pt was to follow up with Pulmonology for repeat CT chest in 6 weeks regarding CTA findings. Other Relevant HX: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P status post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety. Other: COVID infection w/ hospitalization
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sputum discoloured, Streptococcus test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P stats post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety presented to ED on 11/19/22 with 5 days of body aches, productive cough, brown sputum, diarrhea, fever and chills. Pt was recently inpatient for opiate detox until 4 days prior. Pt tested positive for COVID-19 and admitted to hospital. Pt received remdesivir (11/20-11/24), prednisone (11/20-11/26), ceftriaxone (11/20-11/24) and azithromycin (11/20-11/23). Pt treated for COVID and CAP. Pt positive for strep pna on 11/22. Pt continued to improve. Pt stable on 11/26 and discharged to home. Pt was to follow up with Pulmonology for repeat CT chest in 6 weeks regarding CTA findings. Other Relevant HX: 71 yo female patient with past medical history significant for CAD, heart failure, bicuspid aortic valve, CKD, WW P status post ablation, parathyroidectomy, non-small cell lung cancer status post LUL lobectomy 2018, and MDD/anxiety. Other: COVID infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood phosphorus decreased, COVID-19, Cardiac pacemaker evaluation, Cardiac pacemaker replacement, Chest X-ray normal
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient wih PMH for Afib s/p ablation in 05/2022, HTN, remote CVA, pSVT, DDD pacer s/p generator exchange on 07/2022, GERD, PTSD, prostate carcinoma, BPH, and OSA presented to ED on 11/11/22 with SOB, fatigue and syncope x3 in last 2 days. Pacemaker interrogation  revealing for occurrence of SVT, no occurrences in the ED. Pt noted to have low phosphate, repleted in the ED. Pt positive  for COVID-19 without hypoxia and chest x-ray was unremarkable for infiltrates. Pt admitted for further workup and therapy. Pt w/ mild covid symptoms and initially agreed to remdesivir, but changed his mind after speaking to daughter who is also a RN. Pt did receive benzonatate and guaifenesin as needed. Pt remained afebrile and continued to improve. Patient stable and discharged to home on 11/13/2022. Other Relevant HX:  77 yo male patient with PMH for HTN, A fib, GERD, PTSD, prostate carcinoma, BPH, and OSA. Other: Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Condition aggravated, Dyspnoea, Fatigue, SARS-CoV-2 test positive, Supraventricular tachycardia
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient wih PMH for Afib s/p ablation in 05/2022, HTN, remote CVA, pSVT, DDD pacer s/p generator exchange on 07/2022, GERD, PTSD, prostate carcinoma, BPH, and OSA presented to ED on 11/11/22 with SOB, fatigue and syncope x3 in last 2 days. Pacemaker interrogation  revealing for occurrence of SVT, no occurrences in the ED. Pt noted to have low phosphate, repleted in the ED. Pt positive  for COVID-19 without hypoxia and chest x-ray was unremarkable for infiltrates. Pt admitted for further workup and therapy. Pt w/ mild covid symptoms and initially agreed to remdesivir, but changed his mind after speaking to daughter who is also a RN. Pt did receive benzonatate and guaifenesin as needed. Pt remained afebrile and continued to improve. Patient stable and discharged to home on 11/13/2022. Other Relevant HX:  77 yo male patient with PMH for HTN, A fib, GERD, PTSD, prostate carcinoma, BPH, and OSA. Other: Covid Infection w/ hospitalization
Age: 76.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Syncope
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 77 yo male patient wih PMH for Afib s/p ablation in 05/2022, HTN, remote CVA, pSVT, DDD pacer s/p generator exchange on 07/2022, GERD, PTSD, prostate carcinoma, BPH, and OSA presented to ED on 11/11/22 with SOB, fatigue and syncope x3 in last 2 days. Pacemaker interrogation  revealing for occurrence of SVT, no occurrences in the ED. Pt noted to have low phosphate, repleted in the ED. Pt positive  for COVID-19 without hypoxia and chest x-ray was unremarkable for infiltrates. Pt admitted for further workup and therapy. Pt w/ mild covid symptoms and initially agreed to remdesivir, but changed his mind after speaking to daughter who is also a RN. Pt did receive benzonatate and guaifenesin as needed. Pt remained afebrile and continued to improve. Patient stable and discharged to home on 11/13/2022. Other Relevant HX:  77 yo male patient with PMH for HTN, A fib, GERD, PTSD, prostate carcinoma, BPH, and OSA. Other: Covid Infection w/ hospitalization
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Cardiac failure congestive, Cough, Death of companion
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084263:COVID-19; Narrative; 78 yo male patient with PMH for HFrEF (LVEF 35-40% 02/2020), COPD, HTN, and ADHD presented to ED on 11/20/22 with SOB for a few days, worse today w/ dry cough, no relief from inhaler. Pt reported stopping all medications 07/22 after the passing of his girlfriend. Pt was admitted due to elevated BNP in the setting of acute COVID infection. He did not require supplemental oxygen. Pt did receive a dose of furosemide IV. Covid infection thought to likely be causing CHF exacerbation. Pt wanted to leave AMA on 11/21/22. After speaking with provider, pt discharged to home on 11/21/22. Other Relevant HX: 78 yo male patient with PMH for HFrEF (LVEF 35-40% 02/2020). asthma, COPD, HTN, and ADHD, Other: Covid Infection w/ hospitalization
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test positive, Therapy cessation
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084263:COVID-19; Narrative; 78 yo male patient with PMH for HFrEF (LVEF 35-40% 02/2020), COPD, HTN, and ADHD presented to ED on 11/20/22 with SOB for a few days, worse today w/ dry cough, no relief from inhaler. Pt reported stopping all medications 07/22 after the passing of his girlfriend. Pt was admitted due to elevated BNP in the setting of acute COVID infection. He did not require supplemental oxygen. Pt did receive a dose of furosemide IV. Covid infection thought to likely be causing CHF exacerbation. Pt wanted to leave AMA on 11/21/22. After speaking with provider, pt discharged to home on 11/21/22. Other Relevant HX: 78 yo male patient with PMH for HFrEF (LVEF 35-40% 02/2020). asthma, COPD, HTN, and ADHD, Other: Covid Infection w/ hospitalization
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Hypotension, Intensive care, Paracentesis, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 68 yo male patient w/ PMH of NASH cirrhosis, ESRD on HD, DM2, Atrial fibrillation, OSA on CPAP, and DVT presented to ED on 11/01/2022 with low blood pressure. Pt admitted w/concern for SBP and acute decompensated NASH cirrhosis. Pt hasn't had a paracentesis done in 4 weeks due to transportation issues. In ICU Pt had large volume para (11/2), with an output of -10L. Pt was treated for SBP with Ceftriaxone. He stabilized and was downgraded to the floor. Pt BP remained soft but stable. Pt planned for discharge on 11/8. Pt tested positive for COVID 19 on 11/8 and unable to return to SNF for 10 days. Pt given bebtelovimab on 11/9 and remained asymptomatic. Pt discharged to SNF on 11/18/22. Other Relevant HX: 68 yo male patient w/ PMH for NASH cirrhosis, ESRD on HD, DM2, Atrial fibrillation, OSA on CPAP, and DVT. Other: Covid Infection w/ prolonged hospitalization
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spontaneous bacterial peritonitis
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268:COVID-19; Narrative: 68 yo male patient w/ PMH of NASH cirrhosis, ESRD on HD, DM2, Atrial fibrillation, OSA on CPAP, and DVT presented to ED on 11/01/2022 with low blood pressure. Pt admitted w/concern for SBP and acute decompensated NASH cirrhosis. Pt hasn't had a paracentesis done in 4 weeks due to transportation issues. In ICU Pt had large volume para (11/2), with an output of -10L. Pt was treated for SBP with Ceftriaxone. He stabilized and was downgraded to the floor. Pt BP remained soft but stable. Pt planned for discharge on 11/8. Pt tested positive for COVID 19 on 11/8 and unable to return to SNF for 10 days. Pt given bebtelovimab on 11/9 and remained asymptomatic. Pt discharged to SNF on 11/18/22. Other Relevant HX: 68 yo male patient w/ PMH for NASH cirrhosis, ESRD on HD, DM2, Atrial fibrillation, OSA on CPAP, and DVT. Other: Covid Infection w/ prolonged hospitalization
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, COVID-19, Confusional state, Cough, Electrolyte imbalance
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268; COVID-19;     Narrative:  73 yo male patient with PMH significant for CAD s/p CABG, HTN, HLD, Permanent A-fib on warfarin, CKD3b, DM2 and chronic pain presented to ED on 11/09/22 w/ confusion, cough and congestion for 3 days. Pt noted to have fever and HR 140 bpm.  Pt noted to have sepsis, AF w/ RVR, electrolyte imbalance and COVID-19 positive. Pt was fluid resuscitated, placed on broad spectrum antibiotics, Vanc (11/10-11/11) and Zosyn (11/9-11/11) remdesivir (11/9-11/12) and dexamethasone (11/9-11/11) on arrival.  Rapid ventricular rates rom atrial fibrillation responded well to increasing home dose of metoprolol. Pt was quickly hemodynamically stable with the aforementioned treatments. Sepsis attributed to COVID as no bacterial source found. Abx discontinued and pt remained stable. Dexamethasone stopped once pt no longer required oxygen supplementation. Pt improved and discharged to home on 11/13/2022. Other Relevant HX: 73 yo male patient with PMH significant for CAD s/p CABG, HTN, HLD, Permanant A-fib on warfarin, CKD3b, DM2 and chronic pain.  Other: Covid infection w/ hospitalization
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; 10084268; COVID-19;     Narrative:  73 yo male patient with PMH significant for CAD s/p CABG, HTN, HLD, Permanent A-fib on warfarin, CKD3b, DM2 and chronic pain presented to ED on 11/09/22 w/ confusion, cough and congestion for 3 days. Pt noted to have fever and HR 140 bpm.  Pt noted to have sepsis, AF w/ RVR, electrolyte imbalance and COVID-19 positive. Pt was fluid resuscitated, placed on broad spectrum antibiotics, Vanc (11/10-11/11) and Zosyn (11/9-11/11) remdesivir (11/9-11/12) and dexamethasone (11/9-11/11) on arrival.  Rapid ventricular rates rom atrial fibrillation responded well to increasing home dose of metoprolol. Pt was quickly hemodynamically stable with the aforementioned treatments. Sepsis attributed to COVID as no bacterial source found. Abx discontinued and pt remained stable. Dexamethasone stopped once pt no longer required oxygen supplementation. Pt improved and discharged to home on 11/13/2022. Other Relevant HX: 73 yo male patient with PMH significant for CAD s/p CABG, HTN, HLD, Permanant A-fib on warfarin, CKD3b, DM2 and chronic pain.  Other: Covid infection w/ hospitalization